Home » Topics » Regulatory

Regulatory
RSS

Jakafi approved by FDA for steroid-refractory acute GvHD

May 27, 2019

FDA approves Zolgensma for spinal muscular atrophy

May 27, 2019

Actemra approved in Japan for adult-onset Still's disease

May 23, 2019

FDA approves Venclexta with Gazyva for previously untreated CLL or SLL

May 16, 2019

FDA approves Bavencio with Inlyta for advanced renal cell carcinoma

May 15, 2019

FDA approves Eylea to treat all stages of diabetic retinopathy

May 14, 2019

FDA approves Cyramza for hepatocellular carcinoma previously treated with sorafenib

May 13, 2019

Waylivra receives conditional marketing authorization from the European Commission

May 8, 2019

FDA approves Ruzurgi for pediatric patients with Lambert-Eaton myasthenic syndrome

May 7, 2019

FDA approves Kadcyla for adjuvant treatment in HER2-positive early breast cancer setting

May 6, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...